Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 57 (1) , 412-423
Abstract
Context: Shikonins, a series of natural occurring naphthoquinones extracted from Arnebia euchroma (Royle) Jonst. (Boraginaceae), have antitumor activities and low toxicity. Objective: To illuminate potential activity and mechanism of shikonins against colorectal cancer (CRC). Materials and methods: Five shikonins were isolated from A. euchroma, and elucidated by extensive spectroscopic analysis. Anti-proliferative activities of shikonins (0–100 μg/mL) on human colorectal cells were evaluated by MTT and CCK-8 for 24 or 48 h. Cell apoptosis and cycle distribution were examined by FCM analysis. The expression of PI3K/Akt/mTOR pathway mRNAs and proteins was analysed by RT-PCR and Western blot, respectively. Cell viability, cell apoptosis, cell cycle and protein expression were measured, when co-treated with PI3K/Akt/mTOR pathway inhibitors. The in vivo activity of deoxyshikonin was evaluated using xenograft tumour model. Results: Deoxyshikonin and another four shikonins were isolated and identified. Deoxyshikonin exhibited anti-proliferative activity with IC50 of 10.97 μM against HT29 cells. Moreover, the percentage of early apoptotic cells and G0/G1 cells increased from 1 to 29% and 44 to 67% with 0–50 μg/mL deoxyshikonin, respectively. Deoxyshikonin also down-regulated the expression of PI3K, p-PI3K, Akt, p-Akt308 and mTOR proteins in HT29 and DLD-1 cells. Moreover, LY294002, NVP-BEZ235 and MK-2206 can make deoxyshikonin more cell proliferation inhibited, cell cycle arrested at G0/G1 and apoptosis promoted. In vivo study, the weight of tumour tissues at deoxyshikonin groups was significantly reduced compared with the control group, and PI3K, p-PI3K, Akt, p-Akt308 and mTOR expression was decreased. Discussion and conclusions: We can conclude that deoxyshikonin isolated from Arnebia euchroma inhibited CRC through the PI3K/Akt/mTOR pathway.Keywords
Funding Information
- National Natural Science Foundation of China (,)
- Guangdong Medical Research Foundation (414,, 044)
- Natural Science Foundation of Guangdong Province (6, 1)
- Science and Technology Fund of Zhanjiang (4)
- Guangdong Medical Research Foundation (021, 003)
- Traditional Chinese Medicine Research Foundation of Guangdong Provincial Bureau
This publication has 39 references indexed in Scilit:
- Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathwayCancer Letters, 2014
- Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21Cip1 downregulation are required for shikonin-induced apoptosisApoptosis, 2013
- Development of PI3K inhibitors: lessons learned from early clinical trialsNature Reviews Clinical Oncology, 2013
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and SenescenceCell, 2012
- PI3K signalling: the path to discovery and understandingNature Reviews Molecular Cell Biology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- N-(β-Elemene-13-yl)tryptophan methyl ester induces apoptosis in human leukemia cells and synergizes with arsenic trioxide through a hydrogen peroxide dependent pathwayCancer Letters, 2008
- Simultaneous determination of naphthoquinone derivatives in Boraginaceous herbs by high-performance liquid chromatographyAnalytica Chimica Acta, 2006
- Predictive Markers for Colorectal Cancer: Current Status and Future ProspectsClinical Colorectal Cancer, 2003
- Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchromaBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995